KLCM
LLY icon

KG&L Capital Management’s Eli Lilly LLY Stock Holding History

KG&L Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.1M Sell
1,198
-2,940
-71% -$2.98M 0.79% 36
2025
Q4 		$4.45M Sell
4,138
-188
-4% -$180K 1.1% 21
2025
Q3 		$3.3M Sell
4,326
-3,257
-43% -$2.42M 0.88% 27
2025
Q2 		$5.91M Buy
7,583
+2,683
+55% +$2.08M 1.74% 12
2025
Q1 		$4.05M Sell
4,900
-343
-7% -$285K 1.31% 18
2024
Q4 		$4.05M Buy
5,243
+510
+11% +$422K 1.3% 17
2024
Q3 		$4.19M Buy
4,733
+182
+4% +$164K 1.35% 17
2024
Q2 		$4.12M Buy
4,551
+40
+0.9% +$32K 1.43% 16
2024
Q1 		$3.51M Buy
4,511
+94
+2% +$66.9K 1.39% 17
2023
Q4 		$2.57M Buy
4,417
+878
+25% +$512K 1.08% 20
2023
Q3 		$1.9M Sell
3,539
-1,905
-35% -$982K 0.92% 23
2023
Q2 		$2.55M Sell
5,444
-1,345
-20% -$564K 1.22% 18
2023
Q1 		$2.33M Buy
6,789
+3,194
+89% +$1.08M 1.22% 19
2022
Q4 		$1.32M Sell
3,595
-2,834
-44% -$1M 0.76% 30
2022
Q3 		$2.08M Buy
6,429
+375
+6% +$119K 1.17% 24
2022
Q2 		$1.96M Sell
6,054
-207
-3% -$62.1K 1.06% 25
2022
Q1 		$1.79M Buy
6,261
+619
+11% +$159K 0.75% 37
2021
Q4 		$1.56M Buy
5,642
+469
+9% +$119K 0.63% 43
2021
Q3 		$1.2M Buy
5,173
+860
+20% +$212K 0.52% 53
2021
Q2 		$990K Buy
4,313
+386
+10% +$77.5K 0.45% 59
2021
Q1 		$734K Buy
3,927
+319
+9% +$62.4K 0.37% 62
2020
Q4 		$609K Sell
3,608
-6,498
-64% -$970K 0.33% 73
2020
Q3 		$1.5M Buy
10,106
+8,128
+411% +$1.26M 0.94% 28
2020
Q2 		$324K Buy
+1,978
New +$304K 0.25% 74
2020
Q1 		– Sell
-7,887
Closed -$1.04M – 96
2019
Q4 		$1.04M Buy
7,887
+1,753
+29% +$203K 0.88% 35
2019
Q3 		$685K Buy
6,134
+1,425
+30% +$159K 0.62% 42
2019
Q2 		$521K Sell
4,709
-196
-4% -$23.1K 0.5% 54
2019
Q1 		$636K Sell
4,905
-1,332
-21% -$162K 0.64% 48
2018
Q4 		$722K Buy
+6,237
New +$697K 0.81% 38

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

KG&L Capital Management's LLY Position: Q1 2026 in Review

KG&L Capital Management reduced its Eli Lilly (LLY) stake by 71% in Q1 2026, selling an estimated $2.98M and leaving 1,198 shares worth $1.1M. The position accounts for 0.79% of the portfolio, ranked #36.

KG&L Capital Management first reported a position in LLY in Q4 2018 and has held it in 29 quarters since. The position peaked at $5.91M in Q2 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • KG&L Capital Management held 1,198 shares of Eli Lilly worth $1.1M as of Q1 2026.
  • KG&L Capital Management sold 2,940 Eli Lilly shares in Q1 2026, an estimated $2.98M.
  • Eli Lilly made up 0.79% of KG&L Capital Management's portfolio in Q1 2026, its #36 holding.
  • KG&L Capital Management first reported a position in Eli Lilly in Q4 2018 and has held it in 29 quarters since.
  • KG&L Capital Management's Eli Lilly position peaked at $5.91M in Q2 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on KG&L Capital Management's 13F filing for Q1 2026, filed 23 Apr 2026.